Antioxidants targeting ferroptosis, including N-Acetylcysteine (NAC), Vitamin E, Coenzyme Q10, ACSL4 inhibitors, LOX inhibitors, GPX4 activators, and Nrf2 activators, have also shown potential in slowing PD progression in the study. The gene discussed is LOX; the disease is Parkinson disease.